Brooklyn Investment Group purchased a new position in Roche Holding AG (OTCMKTS:RHHBY – Free Report) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 991 shares of the company’s stock, valued at approximately $40,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Bard Financial Services Inc. grew its holdings in shares of Roche by 112.1% during the third quarter. Bard Financial Services Inc. now owns 66,500 shares of the company’s stock valued at $2,657,000 after buying an additional 35,150 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Roche by 57.7% during the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company’s stock valued at $317,000 after buying an additional 2,906 shares during the last quarter. OLD National Bancorp IN grew its holdings in shares of Roche by 3.2% during the second quarter. OLD National Bancorp IN now owns 265,242 shares of the company’s stock valued at $9,206,000 after buying an additional 8,146 shares during the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of Roche during the second quarter valued at $327,000. Finally, Waldron Private Wealth LLC purchased a new stake in shares of Roche during the second quarter valued at $263,000.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on RHHBY shares. Deutsche Bank Aktiengesellschaft lowered shares of Roche from a “hold” rating to a “sell” rating in a report on Friday, September 13th. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a research report on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Roche has a consensus rating of “Hold”.
Roche Stock Performance
RHHBY opened at $36.24 on Friday. Roche Holding AG has a twelve month low of $29.20 and a twelve month high of $42.43. The company has a 50-day moving average price of $38.24 and a 200 day moving average price of $37.44.
Roche Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Read More
- Five stocks we like better than Roche
- What Is WallStreetBets and What Stocks Are They Targeting?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Penny Stocks Ready to Break Out in 2025
- How to invest in marijuana stocks in 7 stepsĀ
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.